Ghent University

Kutatók

• KDKaat Durinck

Futó vizsgálatok

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  NCT07284849· 3. fázis· Incyte Corporation· Forrás

• Toboroz

  Polyphenol Metabotypes in People With Diabetes Type 2

  NCT06810635· University Hospital, Ghent· Forrás

• Toboroz

  A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

  NCT07164443· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)

  NCT07047703· 1/2. fázis· Grey Wolf Therapeutics· Forrás

• Toboroz

  The Muscle Monitor: Early Skeletal Muscle Indicators of Insulin Resistance and Cardiometabolic Risk

  NCT07678736· University Ghent· Forrás

• Meghívásos bevonás

  Mapping Stress and Pain Interactions (G072323N)

  NCT06892977· University Ghent· Forrás

• Fut, nem toboroz

  An open-label study to collect safety and effectiveness information on long-term treatment with vamorolone in boys with Duchenne Muscular Dystrophy who have completed prior studies with vamorolone (The GUARDIAN Study)

  2024-512828-12-00· 4. fázis· Santhera Pharmaceuticals (Schweiz) AG· Forrás

• Toboroz

  A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT06635148· 2/3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Oromyofunctional Training: an Innovative Rehabilitation Program for Pediatric Obstructive Sleep Apnea

  NCT07129967· University Ghent· Forrás

• Toboroz

  Oromyofunctional Therapy: a Rehabilitation Program for OSA in Children With Down Syndrome and Prader-Willi Syndrome

  NCT07122505· University Ghent· Forrás

• Fut, nem toboroz

  Efficacy of Offering a Self-sampling Device by the GP to Reach Underscreened Women

  NCT05656976· University Ghent· Forrás

• Toboroz

  A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

  NCT05748171· 2. fázis· Pfizer· Forrás

• Toboroz

  Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

  NCT05589714· Jaeb Center for Health Research· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy

  NCT05337553· 3. fázis· Biohaven Pharmaceuticals, Inc.· Forrás

• Fut, nem toboroz

  A Study of Rusfertide in Adults With Polycythemia Vera (PV)

  NCT05210790· 3. fázis· Protagonist Therapeutics, Inc.· Forrás

• Fut, nem toboroz

  Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

  NCT05317416· 3. fázis· Pfizer· Forrás

• Fut, nem toboroz

  Metabotyping of Overweight and Obese Children

  NCT04632511· University Ghent· Forrás

• Fut, nem toboroz

  A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma

  NCT04181827· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer

  NCT04165317· 3. fázis· Pfizer· Forrás

• Toboroz

  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  NCT04221035· 3. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás

• Toboroz

  Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

  NCT03852407· 2. fázis· University of Liege· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• 2-es típusú cukorbetegség2 toboroz
• Akut limfoid leukémia (ALL)2 toboroz
• Gyermekkori daganatok2 toboroz
• Obstructive sleep apnoea2 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Down syndrome1 toboroz
• Fibromyalgia1 toboroz
• Hodgkin-limfóma1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Mielóma multiplex1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Neuroblasztóma1 toboroz
• Prosztatarák1 toboroz
• Retinitis pigmentosa1 toboroz
• Spondylitis ankylopoetica (Bechterew-kór)1 toboroz
• Vastagbélrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  Short-Term Effect Of Ceriter Stride One (CSO) on FOG and Falling in pwP

  NCT06204081· University Ghent· Forrás

• Lezárult

  The Influence of the Individual Auditory-cognitive Need on the Aided Benefit Using Different Feature Settings

  NCT06420037· University Ghent· Forrás

• Lezárult

  Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP.

  2024-512646-42-00· 2. fázis· Immunovant Sciences GmbH· Forrás

• Lezárult

  Optimal Dose of a Cognitive Control Training for Depression Vulnerability

  NCT05166798· University Ghent· Forrás

• Lezárult

  An open-label phase 1b/2 study assessing the safety and efficacy of mitazalimab in combination with chemotherapy in patients with metastatic pancreatic ductal adenocarcinoma

  2024-514905-79-00· 1/2. fázis· Alligator Bioscience AB· Forrás

• Lezárult

  Vascular Occlusion for Optimizing Functional Improvement in Patients With Knee Osteoarthritis

  NCT04996680· University Hospital, Ghent· Forrás

• Lezárult

  A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study with a Long-Term Extension Treatment Period to Assess the Efficacy and Safety of JNJ-63733657, an Anti-tau Monoclonal Antibody, in Participants with Early Alzheimer’s Disease

  2022-501188-42-00· 2. fázis· Janssen - Cilag International· Forrás

• Lezárult

  Factors Associated with Falling in Parkinson's Disease

  NCT04440033· University Hospital, Ghent· Forrás

• Lezárult

  A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease

  NCT03737214· 3. fázis· Idorsia Pharmaceuticals Ltd.· Forrás

• Lezárult

  Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]

  NCT03555422· 3. fázis· Karyopharm Therapeutics Inc· Forrás

• Leállították

  A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes

  NCT02841540· 1. fázis· Hemavant Sciences GmbH· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Asztma45 munka · 0 vizsgálat
• Méhnyakrák26 munka · 1 vizsgálat
• Chronic rhinosinusitis with nasal polyps25 munka · 0 vizsgálat
• Krónikus obstruktív tüdőbetegség (COPD)24 munka · 0 vizsgálat
• Hearing loss22 munka · 1 vizsgálat
• Cisztás fibrózis20 munka · 0 vizsgálat
• Szisztémás szklerózis (szkleroderma)20 munka · 0 vizsgálat
• Neuroblasztóma18 munka · 1 vizsgálat
• Spondylitis ankylopoetica (Bechterew-kór)14 munka · 1 vizsgálat
• Fej-nyaki daganatok12 munka · 0 vizsgálat
• Antiphospholipid syndrome10 munka · 0 vizsgálat
• Arthritis psoriatica8 munka · 0 vizsgálat
• Down syndrome7 munka · 1 vizsgálat
• Retinitis pigmentosa7 munka · 1 vizsgálat
• Mezotelióma6 munka · 0 vizsgálat
• Vitiligo4 munka · 0 vizsgálat
• Polymyalgia rheumatica3 munka · 0 vizsgálat